$2.81 +0.15 (%) Biocryst Pharmaceuticals Inc - NASDAQ

Jun. 28, 2016 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. Benzinga's Top Downgrades

    Benzinga | Feb. 9, 2016 | 09:15AM EST
  2. Mid-Afternoon Market Update: Crude Oil Down 3%; Biocryst Pharmaceuticals Shares Drop Following Announcement of Failed Avoralstat Trial Results

    Benzinga | Feb. 8, 2016 | 14:32PM EST
  3. Mid-Day Market Update: Dow Tumbles Over 350 Points; Apollo Education Shares Spike Higher

    Benzinga | Feb. 8, 2016 | 12:05PM EST
  4. Mid-Morning Market Update: Markets Open Lower; Hasbro Beats Q4 Estimates

    Benzinga | Feb. 8, 2016 | 09:53AM EST
  5. BioCryst Pharmaceuticals Is Plummeting 65%

    Benzinga | Feb. 8, 2016 | 08:18AM EST
  6. Biocryst Pharmaceuticals Says Oral Administration Of Avoralstat In Opus-2 Was Generally Safe And Well Tolerated

    Benzinga | Feb. 8, 2016 | 06:03AM EST
  7. 10 Stocks Moving In Tuesday's Pre-Market Session

    Benzinga | Jan. 26, 2016 | 08:26AM EST
  8. Benzinga's Top Downgrades

    Benzinga | Nov. 11, 2015 | 09:45AM EST
  9. Morning Market Losers

    Benzinga | Oct. 8, 2015 | 09:55AM EST
  10. US Stock Futures Down Ahead Of Fed Minutes

    Benzinga | Oct. 8, 2015 | 06:50AM EST
  11. BioCryst Announces Successful Phase 1 Clinical Trial of BCX7353

    Benzinga | Oct. 8, 2015 | 05:59AM EST
  12. Robert Ingram Named to BioCryst's Board of Directors

    Benzinga | Aug. 6, 2015 | 07:36AM EST
  13. 6 Movers To Keep An Eye On Next Week

    Benzinga | Jul. 18, 2015 | 10:18AM EST
  14. FedBizOpps Reporting Biocryst Received $12,133,606 For BCX4430 NDA Enabling CMC and Non-Clinical Toxicology Studies

    Benzinga | Jul. 2, 2015 | 13:34PM EST
  15. Benzinga's Top Upgrades

    Benzinga | Jun. 30, 2015 | 09:50AM EST
  16. Sierra Leone's Freetown Set Back In Ebola Eradication

    Benzinga | Jun. 23, 2015 | 07:04AM EST
  17. Tekmira falls on Ebola news

    IBD | Jun. 19, 2015 | 18:50PM EST
  18. Tekmira Tumbles On Ominous Signs For Ebola Drug

    IBD | Jun. 19, 2015 | 12:49PM EST
  19. An Ebola-Fighting Portfolio For The Present...And The Future

    Benzinga | Jun. 19, 2015 | 10:04AM EST
  20. US Stock Futures Rise Ahead Of Economic Data

    Benzinga | May. 13, 2015 | 07:49AM EST
  21. BioCryst Announces Initiation of a Phase 1 Clinical Trial of BCX7353 for the Treatment of Hereditary Angioedema

    Benzinga | May. 13, 2015 | 06:58AM EST
  22. Benzinga's Top Initiations

    Benzinga | Apr. 21, 2015 | 09:36AM EST
  23. Benzinga's Top Upgrades

    Benzinga | Apr. 20, 2015 | 10:09AM EST
  24. UPDATE: BioCryst Pharmaceuticals Posts Narrower-Than-Expected Q4 Loss

    Benzinga | Feb. 18, 2015 | 08:54AM EST
  25. Benzinga's Top #PreMarket Gainers

    Benzinga | Jan. 14, 2015 | 08:06AM EST
  26. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 3

    Benzinga | Jan. 13, 2015 | 10:58AM EST
  27. Viral Investing: Ebola Drug Makers' Varied Strategies

    IBD | Dec. 26, 2014 | 16:09PM EST
  28. US Stock Futures Edge Higher Ahead Of Economic Data

    Benzinga | Dec. 23, 2014 | 07:08AM EST
  29. BioCryst Pharmaceuticals'

    IBD | Dec. 22, 2014 | 18:28PM EST
  30. Monday's #PreMarket Movers: Caesars, Enta, Twitter And More

    Benzinga | Dec. 22, 2014 | 09:06AM EST
  31. Benzinga's Top #PreMarket Gainers

    Benzinga | Dec. 22, 2014 | 08:09AM EST
  32. US Stock Futures Signal Higher Start On Wall Street

    Benzinga | Dec. 18, 2014 | 07:35AM EST
  33. Market Mixed Amid Plan To Spend $300 Million On Ebola Vaccines

    Benzinga | Dec. 11, 2014 | 14:14PM EST
  34. UPDATE: Bank Of America Reiterates On BioCryst Pharmaceuticals Following EU Physicians Survey

    Benzinga | Dec. 4, 2014 | 10:27AM EST
  35. Ebola Vaccine Contenders

    Benzinga | Oct. 30, 2014 | 10:44AM EST
  36. Making Money With Charles Payne: 10/24/14

    FoxBusiness | Oct. 24, 2014 | 18:00PM EST
  37. Stomach-Churning Ride for Ebola Stocks

    FoxBusiness | Oct. 17, 2014 | 14:52PM EST
  38. Sarepta Therapeutics Shares Up On Ebola Drug Safety Study

    Benzinga | Oct. 17, 2014 | 10:58AM EST
  39. Making Money With Charles Payne: 10/16/14

    FoxBusiness | Oct. 16, 2014 | 18:00PM EST
  40. Making Money With Charles Payne: 10/08/14

    FoxBusiness | Oct. 8, 2014 | 18:00PM EST
  41. Ebola Patient Eric Duncan Dies; Related Stocks Fall On News

    Benzinga | Oct. 8, 2014 | 13:04PM EST
  42. US Stock Futures Edge Higher Ahead Of Alcoa Earnings, Fed Minutes

    Benzinga | Oct. 8, 2014 | 07:19AM EST
  43. Making Money With Charles Payne: 10/07/14

    FoxBusiness | Oct. 7, 2014 | 18:00PM EST
  44. Benzinga's Top #PreMarket Gainers

    Benzinga | Oct. 7, 2014 | 08:10AM EST
  45. BioCryst Reports Late Breaker Presentation of OPuS-1 Phase 2 Trial Results

    Benzinga | Oct. 7, 2014 | 07:10AM EST
  46. Making Money With Charles Payne: 10/0614

    FoxBusiness | Oct. 6, 2014 | 18:00PM EST
  47. Chimerix Ebola Drug OK'd; Tekmira Drops On Downgrade

    IBD | Oct. 6, 2014 | 14:31PM EST
  48. Ebola Sector Shake Out Leaves Chimerix Inc On Top

    Benzinga | Oct. 6, 2014 | 14:08PM EST
  49. U.S. Stocks Turn Red; CareFusion Shares Surge On Announcement Of Acquisition By Becton, Dickinson

    Benzinga | Oct. 6, 2014 | 14:00PM EST
  50. Markets Open Higher; Hewlett-Packard Plans To Split Into Two Companies

    Benzinga | Oct. 6, 2014 | 10:58AM EST
Trading Center